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level [(4542.49561.08) pg/ml vs (4035.11432.65) pg/ml] in levosimendan group
24 hours after treatment. Much more improvement in dyspnea and leg swelling was
seen in levosimendan group 48 hours after treatment. Heart rate was lower in levo-
simendan group [(737.4) bpm vs (878.1) bpm] (P<0.05). However, some adverse
events occurred in levosimendan group and the total incidence of them was 14%
(7 cases with hypotention, 3 cases with headache and 2 cases with hypokalemia).
Conclusions: In patients with DHF, intravenous levosimendan increased the force of
cardiac contraction and provided rapid symptomatic relief. Levosimendan also
increased the risk of adverse events. In order to decrease the adverse events related
harm to the patients caused by levosimendan, nursing management may be of great
value during the treatment. Especially in the ﬁrst several hours of levosimendan
treatment, adverse events should be monitored carefully. Once adverse events occur or
symptoms get worse, they must be immediatly reported to the doctors to adjust the
treatment.
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Objectives: To investigate associations among anemia and renal insufﬁciency,
Neurohormonal Cytokines Activation in Elderly patients with congestive heart failure
(CHF), and study their inﬂuence on left ventricular mass index (LVMI), mean wall
stress (MWS) and cardiac function.
Methods: 121 CHF patients were divided into the anemic group (n¼47) and the non-
anemic group (n¼74), Hb concentration, renal function, serum tumor necrosis factor-a
(TNF-a), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-1 (IL-6),
AngiotensinII (AngII) were measured. left ventricular ejection fraction (LVEF), LVMI
and MWS were measured by echocardiography.
Results: Hb concentration signiﬁcantly decreased, and the level of BUN, Cr increased
with deterioration of cardiac function in CHF patients. 38.8% of patients had anemia,
and 24% had renal insufﬁciency. the anemia and renal insufﬁciency aggravated with
decreaseing LVEF. TNF-a, sICAM-1, IL-6, AngII levels, LVMI and MWS were
higher in the anemic patient group than those in the non- anemic subject group
[(92.336.39) vs (55.6310.16) ng/L, (253.5825.96) vs (237.1833.26) ug/L,
(145.2213.53) vs (106.520.36) ug/L, (144.5364.12) vs (76.6948.49) pg/ml,
(187.78.5 ) vs (108.49.3) g/m2 and (481.125.8) vs (361.823.1) dynes103/
cm2, all P<0.01 respectively]. LVEF was signiﬁcantly decreased in the anemic patient
group compared with that in the non- anemic subject group[(33.945.23) vs
(45.358.82) P<0.01], With the increased with the severity of anemia, the levels of
TNF-a, sICAM-1, IL-6, AngII, LVMI and MWS signiﬁcantly increased; there were
positive correlation between LVMI, MWS and TNF-a, sICAM-1, IL-6, AngII levels
(P<0.01), and a negative correlation between TNF-a, sICAM-1, IL-6, AngII, LVMI,
MWS and Hb concentration (P<0.01).
Conclusions: Neurohormonal and Cytokines Activation play roles in pathophysio-
logical and pathogenetic mechanism of the severity of ventricular remodeling and
anemia, and the occurrence of anemia aggravates the change of ventricular remodeling
in CHF.
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Objectives: To evaluate whether alpha-1blocker provide additional therapeutic ben-
eﬁts than other traditional medications which are currently employed in clinical
setting, the safety and efﬁcacy of urapidil and nitroglycerin on the treatment of elderly
HF patients with hypertension and DM is investigated in a multi-center randomized
and parallel-control trial study.
Methods: 72 elderly patients were randomized into two groups with urapidil (n¼35;
M/F¼19/16) or nitroglycerin (n¼37; M/F¼20/17) treatment. Urapidil and nitroglyc-
erin are deployed with microinfusion pump with the following concentrationC184 JACC Vol 64/16/Suppl C j October 16–1respectively: 50-300 mg / min (urapidil) and 5-20 mg /kg/min (nitroglycerin). Depot
time for both of the drugs is adjusted according to individual clinical setting and lasts
for about 48-140 hours. Blood pressure (BP), heart rate (HR), metabolic panel and
cardiovascular function (NT-proBNP, EF, LVCO, LVEDV, ect.) are measured before
and after the treatment (0 hour, 24 hours, 48 hours, 72 hours and 7 days).
Results: Patients with urapidil exerted signiﬁcantly lower systolic blood pressure
(SBP) than their counterparts in the nitroglycerin group. Moreover, urapidil effectively
ameliorated the NT-proBNP level after treatment. In urapidil treatment group, EF, CI
and LEDV patients were signiﬁcantly improved compared to the patients with
nitroglycerin treatment. Both of these two drugs caused a decrease of fasting plasma
glucose (FPG). But, there was no signiﬁcant difference in FPG of patients between
urapidil- and nitroglycerin-treated groups.
Conclusions: Urapidil had better efﬁcacy than nitroglycerin on lowering and stabi-
lizing the SBP in elderly patients, attenuating the afterload and improving the cardiac
function by affecting the EF, LEDV. Like nitroglycerin, Urapidil signiﬁcantly reduced
the FPG of HF patients with DM without causing adverse effects on metabolic proﬁle
in these patients. While offering an effective way for handling BP of multifactor HF
patients who are complicated with hypertension and DM, Urapidil may provide
additional therapeutic beneﬁts to these patients. Urapidil may be another ﬁrst-line
medication in terms of its mild side effects.
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Objectives: Experimental data have suggested that Bone Mesenchymal cell (MSC )
may contribute to the healing of myocardial infarction (MI). We also have certiﬁed
that MSC is effective in treating DCM, for this reason, we treat one dialated car-
diomyopathy (DCM) patient with autologous BMCs.
Methods: One dialated cardiomyopathy (DCM) with heart failure patient were
transplanted with autologous BMCs via the coronary artery. The ejection fraction (EF)
was assessed by echocardiography before and 4, 8, 17, 21, 30, 60 days after MSC
transplantation.
Results: The MSC Transplantation had signiﬁcant sustained improvements in left
ventricular ejection fraction from before transplant (0.26), to 4, 8, 17, 21, 30, 60 days
after cell implantation (0.57, 0.52, 0.55, 0.53, 0.51, 0.45 respectively).
Conclusions: Our data demonstrate that intracoronary transplantation of autologous
BMCs improved cardiac function in DCM patient with a markedly greater improve-
ment. This approach opens a new window in the treatment of ‘no hope’ patients with
congestive heart failure.
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Objectives: To analysis the related factors of perioperative heart failure in patients
with acute STEMI undergoing emergency PCI.
Methods: The study involves 227 patients who suffered the ﬁrst acute STEMI and
accepted the treatment of emergency PCI. Record the general information of all
patients including age, gender, the history of hypertension, diabetes, high cholesterol
and smoking, the pain to balloon time, the site of myocardial infarction and the infarct
related coronary artery and whether with multi vessel disease. Record the use of
thrombus aspiration and tiroﬁban and the postoperative TIMI grade of blood ﬂow and
the. Record the speciﬁc numerical about WBC, the percentage of neutrophils, neu-
trophils to lymphocytes ratio (NLR) and mean platelet volume (MPV).Within 2 hours
after PCI again for the 12 lead ECG and record the level of ST resolution (STR)
compared with the ECG before PCI. Deﬁned the STR 50% and the STR >50%.
Record LVEF according to the cardiac ultrasound echocardiography one week after
PCI. Deﬁne LVEF 45% as heart failure group and LVEF>45% as the non heart
failure group. All the data were analyzed by statistical software SPSS17.0. The dif-
ference was statistically signiﬁcant when P<0.05.
Results: Compared with the non heart failure group, in heart failure group, the
average age (61.0812.62 vs 57.6610.78) is bigger, the average time of chest pain
to balloon (5.413.24 vs 4.412.80) is longer, the proportion of the anterior
descending branch as the infarct related coronary artery (65% vs 48%) is higher, the
proportion of the anterior wall as the site of myocardial infarction (60% vs 35%) is
higher, the proportion of using the tiroﬁban (24% vs 38%) is lower, the proportion of
postoperative TIMI grade of blood ﬂow <3 (11% vs 3%) is higher, the total number of
WBC (11.433.05 vs 10.483.02) is bigger, the percentage of neutrophils
(82.208.16 vs 73.5813.45) is higher, the NLR (8.664.13 vs 5.253.47) is
higher, and there were statistically signiﬁcant differences between the two groups
(P<0.05). Multi factor regression analysis showed that STR  50% 2 hours after PCI
and long time of chest pain to balloon are two relatively independent risk factors of
heart failure during perioperative period of emergency PCI. Linear correlation analysis
showed that the age (r¼-0.190, P¼0.004), the total number of WBC (r¼-0.134,9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
